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An Honors Thesis submitted in partial fulfillment of the requirements for Honors in
Chemistry.
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Under the mentorship of Dr. Abid Shaikh

ABSTRACT
Over the past decade, synthesis of organofluorine compounds has become a mainstream
research focus. The introduction of fluorine uniquely affects the biological properties of
organic molecules such as making them more bioavailable, lipophilic and metabolically
stable, and possibly increase the strength of a compound’s interactions with a target protein.
Approximately 30% of agrochemicals and 20% of pharmaceuticals contain fluorine,
including commonly prescribed drugs such as Lipitor, Lexapro and Prozac. This work
describes the development of a new methodology to incorporate fluorine into organic
compounds. Our new method involves a regioselective electrochemical 5,8-difluorination
of quinolines using HF:pyridine as both the reagent and supporting electrolyte. Various
quinoline derivatives were subjected to electrolytic fluorination at room temperature to
obtain moderate to good yields in a short reaction time of two hours.
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Introduction
A biosynthetic pathway of incorporating fluorine into organic molecules was only
discovered twelve years ago. O’Hagan et al.1 demonstrated the enzymatic incorporation of
fluoride to form fluoroacetate. The less evolved natural use of fluorine, compared to other
halogens, is believed to be linked to the low solubility of most fluoride minerals; this
sequestration of fluoride in inorganic compounds prevents biological accumulation and
incorporation.2
Despite the absence of naturally fluorinated organic compounds, organofluorine
chemistry has received extensive attention in recent years especially in the pharmaceutical
industry and in materials science due to the unique properties of fluorinated compounds.3
The strong electron-withdrawing effect of fluorine contributes to a number of biologically
important molecular properties.4 For example, it results in a significant increase in
lipophilicity of the molecule, which is a very important feature for drug delivery as it
increases the bioavailability of molecules traversing cellular membranes.5 Because fluorine
has a van der Waals radius comparable to that of hydrogen, 1.35 Å vs 1.20 Å, substituting
hydrogen with fluorine does not impact recognition by protein binding sites.6 The increased
lipophilicity and a superior metabolic stability, compared to the use of methyl analogues,
often accounts for an improved activity profile.7 The different medicinal applications of
fluorinated organic molecules are widespread; some of the most commonly utilized drugs
are Prozac® (anti-depressant), Diflucan® (anti-fungal agent), Casodex® (anti-cancer
agent), and Desflurane (inhalation anesthetic).8 Recent applications of organofluorine
compounds include potential therapeutics for HIV, cancer, and Alzheimer’s disease.9
2

Accordingly, the synthesis of these molecules is in great demand and the search for new
biologically active fluorinated compounds is in the forefront of organic and medicinal
chemistry research.

Figure 1. Literature overview of various fluorine incorporation methods.

The significance of fluorine incorporation into organic molecules has been well
documented in the literature.10 Despite the growing importance of fluorine-containing
drugs, incorporation of a fluorine atom at a specified position of heterocycles still presents
a challenge. Current reported methods involve the nucleophilic substitution of a chloride
with a fluoride anion.11 Even though the process involves mild reaction conditions, it still
requires the synthesis of a chloride precursor. Ideally, the most straightforward approach
to the synthesis would involve the transformation of a C-H bond to a C-F bond by using a
widely available fluorinating reagent. Herein, we describe the use of HF:pyridine (Olah’s
reagent) for the synthesis of 5,8-difluoroquinolines. Previous investigations with
3

quinolines using elemental fluorine under acidic conditions (F2/H2SO4) provided
exclusively 5-fluoroquinoline product with a trace amount 5,8-difluoroquinoline.12 Our
synthetic strategy involves electrolysis using Olah’s reagent as both the solvent and
supporting electrolyte. This work demonstrates the successful extension of electrolytic
fluorination method described by Savett (Figure 1).

Results and discussion
Our original goal was to achieve the acid-catalyzed C-H functionalization of quinaldine
to incorporate fluorine. We started our study by choosing the reaction of quinaldine 1 with
HF:pyridine (70:30) as the model. To our surprise, the fluorination product 3 at the 2methyl position of quinoline was not observed. Instead, an unexpected 5,8-difluoro product
2 was obtained in 70% yield.
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Figure 2. Regioselective difluorination of quinoline and its derivatives. Reaction
conditions: 2-methylquinoline (100mg), HF:pyridine (4 mL), 2.4V, 2h.
Encouraged by this result, we further investigated the reaction to optimize the
experimental conditions. The reaction proceeded rapidly at room temperature in higher
yield. There was no significant improvement in the product yield observed even after an
extended amount of time.
With the optimized conditions in hand, the scope of this reaction was further
investigated with various substituted quinolines. Results showed that a wide range of
substituted quinolines reacted smoothly to form the corresponding 5,8-difluoro products 411 (Figure 2). The substrates bearing a methyl group on the pyridinyl ring reacted to
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produce good yields. In addition, 1-methylisoquinoline and 2-methylpyrazine substrates
also afforded the expected products in good yields. Intriguingly, the reactions with
halogenated quinolines, such as product 8, provided the expected products without the loss
of the original halogens. In each case, selective fluorination occurred on the benzenoid ring
only; protonation of the heteroatom under the strong acidic reaction conditions causes
deactivation of the heterocyclic ring.
To investigate the general efficacy of this method, we further investigated the
fluorination of various complex molecules bearing the quinoline core.

Biquinoline,

acridine, and papaverine were subjected to electrolysis under similar reaction conditions as
described above. Biquinoline provided the expected product 12 with fluorination occurring
at both the quinoline rings. Acridine provided a 1,4,5,8-tetrafloroproduct 13 and papaverine
provided the 5,8-difluoro product 14 (Figure 3).

Figure 3. Regioselective difluorination of complex quinoline derivatives.
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Figure 4. 1H NMR spectra of product 2 showed a unique pattern of signals in the aromatic
range confirming the 5,8-difluorination occurred at the benzenoid ring.
Conclusion
In summary, we have developed a novel highly regioselective direct 5,8-difluorination
of quinolines with Olah’s reagent under electrolytic conditions. The methodology utilized
in this experiment gave primarily moderate to good yields with various quinoline
derivatives under mild reaction conditions and a short reaction time of two hours. This
leads to the conclusion that this straightforward and effective reaction provides a new way
to synthesize organofluorine compounds, which may open new possibilities in future
chemical and biochemical applications.
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Appendix: Experimental Procedure and Product Characterization
Experimental procedure
The quinoline (100mg) was transferred into a polypropylene syringe prepared by melting
the barrel tip and adding a stir bar to form the reaction vessel. The quinoline was dissolved
in 4 mL of HF:Pyridine, and the solution was stirred. The platinum electrodes were inserted
into the reaction vessel, and an eDAQ ER466 potentiostat was used to push 100 mA in a
repetitive step every five seconds alternating from -2.4V to 2.4V for two hours. After the
reaction was complete, the excess acid was neutralized by adding the solution dropwise
into a slurry of sodium bicarbonate. Once neutralized, the mixture was washed in ethyl
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acetate, and the organics were isolated using a separatory funnel. The product mixture was
filtered through anhydrous sodium sulfate and concentrated using a Buchi RotaVapor R200. The crude mixture was dissolved in dichloromethane and purified using normal phase
chromatography with a hexane/ethyl acetate system to obtain the expected compounds in
high analytical purity. The product analysis and characterization using various spectral
techniques was carried out and the data is summarized as below.

Product Characterization
5,8-difluoro-2-methylquinoline (2)

Yellow-brown solid, m.p. 71.9-73.7°C
1

H-NMR (400 MHz, CDCl3) δ (ppm) 8.33 – 8.27 (m, 1H), 7.42 – 7.38 (m, 1H), 7.32 –

7.26 (m, 1H), 7.09 – 7.02 (m, 1H), 2.81 (s, 3H), 19F-NMR (376.22 MHz, CDCl3 δ (ppm) 127.16 – -127.30 (m, 1F), -130.03 – -130.36 (m, 1F)

5,8-difluoroquinoline (4)
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Red-brown liquid
1

H-NMR (400 MHz, CDCl3) δ (ppm) 8.94 – 8.88 (m, 1H), 8.15 – 8.10 (m, 1H), 7.62 – 7.57

(m, 1H), 6.58 – 6.46 (m, 2H)
19

F-NMR (376.22 MHz, CDCl3 δ (ppm) -87.64 (m, 1F), -94.86 (m, 1F)

5,6,8-trifluoro-2-methylquinoline (5)

Yellow liquid
1

H-NMR (400 MHz, CDCl3) δ (ppm) 7.89-7.85 (m, 1H), 7.24-7.16 (m, 1H), 6.91-6.87 (m,

1H), 6.31-6.23 (m, 1 H), 2.58 (s, 3H), 19F-NMR (376.22 MHz, CDCl3 δ (ppm) -120.65 – 120.76 (m, 1F), -120.99 – -121.12 (m, 1F)
6-bromo-5,8-difluoro-2-methylquinoline (6)

Yellow solid, m.p. 125.5-127.91°C
1

H-NMR (400 MHz, CDCl3) δ (ppm) 8.26 – 8.22 (m, 1H), 7.50 – 7.45 (m, 1H), 7.42 –

7.38 (m, 1H), 2.76 (s, 3H), 19F-NMR (376.22 MHz, CDCl3 δ (ppm) -120.41 – -120.54 (m,
1F), -128.22 – -128.35 (m, 1F)
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5,8-difluoro-2,6-dimethylquinoline (7)

Yellow liquid
1

H-NMR (400 MHz, CDCl3) δ (ppm) 7.95 – 7.91, 7.35 – 7.32 (m, 1H), 5.89 – 5.67 (m,

1H), 5.07 – 4.82 (m, 1H), 2.68 (d, J = 2.0 Hz, 3H), 1.77 (t, J = 15.6 Hz, 3H)

8-chloro-5-fluoro-2-methylquinoline (8)

Yellow-brown liquid
1

H-NMR (400 MHz, CDCl3) δ (ppm) 8.01 – 7.95, 7.41 – 7.37 (m, 1H), 7.92 – 7.89, 7.27 –

7.24 (m, 1H), 6.73 – 6.66, 6.30 – 6.23 (m, 1H), 5.35 – 5.16 (m, 1H), 2.68 (d, J = 21.4 Hz,
3H)

4-chloro-5,8-difluoro-2-(trifluoromethyl)quinolone (9)
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Light orange solid, m.p. 60.3-62.4°C
1

H-NMR (400 MHz, CDCl3) δ (ppm) 7.87 – 7.86 (m, 1H), 7.52 – 7.46, 7.39 – 7.32 (m,

1H), 6.61 – 6.47 (m, 1H), 19F-NMR (376.22 MHz, CDCl3 δ (ppm) -67.88 – -67.90 (m,
1F)

5,8-difluoro-2-methylquinoxaline (10)

Red-pink solid, m.p. 68.8-72.3°C
1

H-NMR (400 MHz, CDCl3) δ (ppm) 8.76 (s, 1H), 7.44 – 7.41 (m, 1H), 7.35 – 7.32 (m,

1H), 3.40 (s, 1H), 19F-NMR (376.22 MHz, CDCl3 δ (ppm) -95.27 – -95.36 (m, 1F), -95.54
– -95.63 (m, 1F)
5,8-difluoro-1-methylisoquinoline (11)
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Yellow-white solid, m.p. 81.7-83.1°C
1

H-NMR (400 MHz, CDCl3) δ (ppm) 8.44 – 8.40 (m, 1H), 7.66 – 7.61 (m, 1H), 7.23 –

7.17 (m, 1H), 7.13 – 7.04 (m, 1H), 3.02 (d, J = 7.0 Hz, 3H), 19F-NMR (376.22 MHz, CDCl3
δ (ppm) -113.35 – -113.57 (m, 1F), -126.44 – -126.56 (m, J = 22.9, 8.9, 4.3 Hz, 1F)

1,4,5,8-tetrafluoroacridine (13)

Yellow solid, m.p. 113.3-115.9°C
1

H-NMR (400 MHz, CDCl3) δ (ppm) 9.32 – 9.01 (m, 1H), 8.11 – 8.02 (m, 1H), 7.88 – 7.55

(m, 1H), 7.49 – 7.32 (m, 1H), 7.21 – 7.15 (m, 1H), 7.13 – 6.39 (m, 1H), 5.99 – 5.80 (m,
1H)
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